Moderna

YTD

ALL

Trade Moderna 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.

CEO

Stéphane Bancel

CEOStéphane Bancel

Employees

5,800

Employees5,800

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2010

Founded2010

Employees

5,800

Employees5,800

MRNA Key Statistics

Market cap

11.19B

Market cap11.19B

Price-Earnings ratio

-3.16

Price-Earnings ratio-3.16

Dividend yield

—

Dividend yield—

Average volume

8.92M

Average volume8.92M

High today

$29.60

High today$29.60

Low today

$26.51

Low today$26.51

Open price

$27.58

Open price$27.58

Volume

16.28M

Volume16.28M

52 Week high

$91.99

52 Week high$91.99

52 Week low

$23.15

52 Week low$23.15

MRNA News

CNBC 2d

Moderna cuts high end of 2025 revenue outlook on vaccine shipment delay in U.K.

Moderna on Friday lowered the high end of its 2025 revenue outlook due to a delay in vaccine shipments to the U.K., but beat Wall Street's expectations for the...

CNBC 3d

Moderna to slash 10% of workforce as biotech cuts costs, Covid shot sales slow

Moderna on Thursday said it plans to slash roughly 10% of its global workforce by the end of the year, as Covid shot sales continue to dwindle and the company g...

CNBC 3d

Pandemic darlings Moderna, BioNTech are now on two different paths

In this article BMY BNTX MRNA Follow your favorite stocks CREATE FREE ACCOUNT A researcher works in the lab at the Moderna Inc. headquarters in Cambridge, Ma...

Analyst ratings

64%

of 28 ratings

Buy

21.4%

Hold

64.3%

Sell

14.3%

People also own

Based on the portfolios of people who own MRNA. This list is generated using Robinhood data, and it’s not a recommendation.